Fatty Liver: all 1,462 studies
Page 7 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Health Effects of Biostimulated Lettuce in HumanCompletedNCT05971017Not applicable
- Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).Active, not recruitingNCT05946330Not applicable
- Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)CompletedNCT05946148
- Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)CompletedNCT05935826Phase 3
- Night Hyperglycemia and Fatty Liver in Type 1 DiabetesCompletedNCT05933018Not applicable
- Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function in Postmenopausal Women With Overweight and ObesityStatus unknownNCT05912309Not applicable
- Comparing Effects of Beetroot Juice and Mediterranean Diet on Liver Enzymes and Sonography in Patients With NAFLDCompletedNCT05909631Phase 1
- Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLDCompletedNCT05897606Phase 1
- Time-Restricted Eating, Exercise and Cardiometabolic Health in ObesityCompletedNCT05897073Not applicable
- A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLDCompletedNCT05885373Not applicable
- Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge DrinkCompletedNCT05882214Phase 1/2
- Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis BCompletedNCT05871749
- Effects of Time-restricted Hypocaloric Diet in Patients with NAFLDCompletedNCT05866744Not applicable
- A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.TerminatedNCT05864391Phase 1
- Liver Biomarkers in Anorexia NervosaCompletedNCT05861375
- Quantification of Hepatic Steatosis With Different Ultrasound FrequencyActive, not recruitingNCT05855239
- Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.Status unknownNCT05849220Not applicable
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy ParticipantsCompletedNCT05848440Phase 1
- Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeCompletedNCT05843955
- A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCompletedNCT05835180Phase 1
- CM-101 in NASH Patients - The SPLASH StudyCompletedNCT05824156Phase 2
- Semaglutide in Nonalcoholic Fatty Liver DiseaseCompletedNCT05813249Phase 4
- Non-Alcoholic Fatty Liver Disease and Anthropometric MeasurementsCompletedNCT05810506
- A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver HealthCompletedNCT05808049Not applicable
- Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal ObesityCompletedNCT05807204Not applicable
- Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD)CompletedNCT05804955
- Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)CompletedNCT05804422Not applicable
- Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease PatientsStatus unknownNCT05804409
- Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05802199
- Fibrosis Reduction in Non Alcoholic SteatohepatitisActive, not recruitingNCT05798702Not applicable
- Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）CompletedNCT05795517Phase 2
- Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and SteatosisStatus unknownNCT05786963
- Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot StudyActive, not recruitingNCT05782972Phase 4
- Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD)CompletedNCT05778266Not applicable
- Diabetes Prevention and EducationWithdrawnNCT05769127Not applicable
- Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT05768334Phase 3
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedNCT05766709Phase 1
- Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-surveyCompletedNCT05765890
- SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With ObesityCompletedNCT05764811Not applicable
- A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedNCT05742919Phase 1
- NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced FibrosisStatus unknownNCT05734599
- A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedNCT05727644Phase 1
- The Nijmegen-Leiden-Amsterdam 2-tiered Care Path StudyCompletedNCT05712603
- Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of MiricorilantCompletedNCT05712265Phase 1
- Effect of Indian Hepatoprotective Diet in Reversibility of NAFLDStatus unknownNCT05696808Not applicable
- Body Composition and Fatty Liver DiseaseActive, not recruitingNCT05695118Not applicable
- Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue AssessmentCompletedNCT05694923Not applicable
- A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)Active, not recruitingNCT05692492Phase 2
- Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLDStatus unknownNCT05686174Phase 1
- Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis PatientsStatus unknownNCT05679648
- Hepatic Steatosis and Chronic Hepatitis B VirusCompletedNCT05678582
- A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy ParticipantsTerminatedNCT05668936Phase 1
- Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT05654129Not applicable
- SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic OutcomesStatus unknownNCT05637866
- Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLDStatus unknownNCT05635474Not applicable
- Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty LiverStatus unknownNCT05623930Not applicable
- Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease PatientsStatus unknownNCT05613192Phase 3
- Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver DiseaseCompletedNCT05611567Not applicable
- Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisStatus unknownNCT05605158Phase 3
- First Human Dose Trial for a New Medication to Potentially Treat Liver DiseasesCompletedNCT05599945Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASHCompletedNCT05591079Phase 2
- N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver DiseaseCompletedNCT05589584Phase 3
- Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled TrialCompletedNCT05579158Not applicable
- High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05578404Phase 2
- Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients with HyperuricemiaActive, not recruitingNCT05574036Phase 2
- Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic SteatohepatitisActive, not recruitingNCT05573204Phase 2
- Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT05556135
- Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of MiricorilantCompletedNCT05553470Phase 1
- FTIH of ECC4703 in Healthy VolunteersCompletedNCT05552274Early Phase 1
- Weight Gain After Smoking Cessation and NAFLDCompletedNCT05550688
- Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease PatientsCompletedNCT05546450Not applicable
- Relation Between Carotid Atheroscerosis With DM &Fatty LiverStatus unknownNCT05532553
- Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese ChildrenCompletedNCT05527938Not applicable
- Clinical Epidemiology of NAFLD in Children and AdolescentsStatus unknownNCT05526274
- Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLDCompletedNCT05523648Early Phase 1
- Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL.Status unknownNCT05523024Not applicable
- Exercise and Cerebral Hemodynamics in MAFLD.Status unknownNCT05520697Not applicable
- First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT05517564Phase 1
- Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05513729
- Treating Pediatric NAFLD with NutritionCompletedNCT05499585Not applicable
- An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT05497765Not applicable
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseCompletedNCT05493761Phase 4
- Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by UltrasoundStatus unknownNCT05486429
- Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced FibrosisCompletedNCT05485714
- Non-alcoholic Fatty Liver Disease and Its TreatmentCompletedNCT05480007Not applicable
- LITMUS Imaging StudyActive, not recruitingNCT05479721
- Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD PatientsCompletedNCT05474560Phase 4
- Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASHActive, not recruitingNCT05462353Phase 2
- Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT05459701Phase 4
- Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.CompletedNCT05441904Phase 1
- A Digital Solution for Individuals With Non Alcoholic Fatty Liver DiseaseCompletedNCT05426382Not applicable
- Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)TerminatedNCT05423327Not applicable
- Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05422092Not applicable
- Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Status unknownNCT05421572
- Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver DiseaseCompletedNCT05419765
- The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease EvolutionCompletedNCT05416970
- To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota ModulationCompletedNCT05402449Not applicable
- A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic SteatohepatitisCompletedNCT05397379Phase 2
- A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)CompletedNCT05395481Phase 1
- The Visceral Adiposity Measurement and Observation StudyCompletedNCT05383456